Kura Oncology, Inc. (KURA) ownership: Top institutional holder: BlackRock, Inc. ($78.35M). Insider activity: Net Seller (0 buys, 8 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 9637531.00 | $78.35M | 2026-03-31 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8575422.00 | $69.72M | 2026-03-31 |
| BVF INC/IL | 8445769.00 | $68.66M | 2026-03-31 |
| VANGUARD GROUP INC | 5507627.00 | $57.22M | 2025-12-31 |
| STATE STREET CORP | 4511891.00 | $36.68M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3785685.00 | $30.78M | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 3736000.00 | $30.37M | 2026-03-31 |
| Prosight Management, LP | 3356700.00 | $27.29M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-21 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-03-23 | |
| Sell | null | 2026-03-23 | |
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 |
Back to KURA overview · KURA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.